Literature DB >> 25977097

CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation.

Yuko Tanabe1, Eriko Fujita-Jimbo1,2, Mariko Y Momoi1, Takashi Momoi1,3.   

Abstract

Autism spectrum disorder (ASD) is a developmental brain disorder. Mutations in synaptic components including synaptic adhesion molecules have been found in ASD patients. Contactin-associated protein-like 2 (CASPR2) is one of the synaptic adhesion molecules associated with ASD. CASPR2 forms a complex with receptors via interaction with multiple PDZ domain protein 1 (MUPP1). Little is known about the relationship between impaired CASPR2-MUPP1-receptor complex and the pathogenesis of ASD. GPR37 is a receptor for survival factors. We recently identified mutations including R558Q in the G-protein-coupled receptor 37 (GPR37) gene in ASD patients. The mutated GPR37s accumulate in the endoplasmic reticulum. In this study, we show that GPR37 is a component of the CASPR2-MUPP1 receptor complex in the mouse brain. CASPR2 and GPR37 mainly interacted with the PDZ3 and PDZ11 domains of MUPP1, respectively. Compared to GPR37, GPR37(R558Q) slightly interacted with MUPP1 and caused dendritic alteration. GPR37, but not GPR37(R558Q) nor GPR37-deltaC which lacks its PDZ binding domain, was transported to the cell surface by MUPP1. In primary hippocampal neurons, GPR37 co-localized with MUPP1 and CASPR2 at the synapse, but not GPR37(R558Q). Thus, ASD-related mutation of GPR37 may cause the impaired CASPR2-MUPP1-GPR37 complex on the dendrites associated with one of the pathogenesis of ASD. In this study, we identified that GPR37 is a component of the MUPP1 and CASPR2 receptor complex. Autism deleterious mutated GPR37(R558Q) slightly interacts with MUPP1 and retains in ER, resulting in dendritic alteration. In neuron, GPR37, but not GPR37(R558Q), is transported to the dendrite and synapse by MUPP1. Thus, ASD-related mutation of GPR37 may cause the impaired CASPR2-MUPP1-GPR37 complex on the dendrites associated with one of the pathogenesis of ASD.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  CASPR2; GPR37; MUPP1; PDZ; autism spectrum disorder

Mesh:

Substances:

Year:  2015        PMID: 25977097     DOI: 10.1111/jnc.13168

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Disconnecting CNTNAP2.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2016-06-17

Review 2.  Intragenic CNTNAP2 Deletions: A Bridge Too Far?

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-02-10

3.  Osteocalcin Alleviates Lipopolysaccharide-Induced Acute Inflammation via Activation of GPR37 in Macrophages.

Authors:  Zhengjiang Qian; Chunhua Liu; Hongchao Li; Haiyang Yang; Jianhao Wu; Jing Liu; Yanjiao Li; Xuhui Chen; Jianyang Xu; Xiang Li
Journal:  Biomedicines       Date:  2022-04-27

4.  Longitudinal DNA methylation dynamics as a practical indicator in clinical epigenetics.

Authors:  Shohei Komaki; Hideki Ohmomo; Tsuyoshi Hachiya; Yoichi Sutoh; Kanako Ono; Ryohei Furukawa; So Umekage; Yayoi Otsuka-Yamasaki; Kozo Tanno; Makoto Sasaki; Atsushi Shimizu
Journal:  Clin Epigenetics       Date:  2021-12-13       Impact factor: 6.551

Review 5.  Mouse Mutants of Gpr37 and Gpr37l1 Receptor Genes: Disease Modeling Applications.

Authors:  Marzia Massimi; Chiara Di Pietro; Gina La Sala; Rafaele Matteoni
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

Review 6.  Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1.

Authors:  Nicola J Smith
Journal:  Front Pharmacol       Date:  2015-11-17       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.